Zhou Lihan
Amministratore Delegato presso MiRXES Pte Ltd.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Zou Ruiyang | M | 38 |
Ark Bio Holding Pte Ltd.
 Ark Bio Holding Pte Ltd. Financial ConglomeratesFinance Ark Bio Holding Pte Ltd. operates as an investment holding company. The firm offers end-to-end solutions focused on cancer early detection. The company was founded by Isaac Ho, Zhou Lihan and Zou Ruiyang in 2018 and is headquartered in Singapore.
MiRXES Pte Ltd.
 MiRXES Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MiRXES Pte Ltd. is a held life science research tool provider and miRNA diagnostic test developer. Its products and services include IDEAL miRNA knowledge, IDEAL miRNA assays, knowledge panel profiling service, cutomization assay and premium biomarker discovery solution. The company was founded by Zhou Lihan, Zou Ruiyang, and Too Heng Phon and is headquartered in Singapore.
Mirxes Holding Co., Ltd.
 Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 10 anni |
| Hou Chiat Ho | M | 48 |
MiRXES Pte Ltd.
MiRXES Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MiRXES Pte Ltd. is a held life science research tool provider and miRNA diagnostic test developer. Its products and services include IDEAL miRNA knowledge, IDEAL miRNA assays, knowledge panel profiling service, cutomization assay and premium biomarker discovery solution. The company was founded by Zhou Lihan, Zou Ruiyang, and Too Heng Phon and is headquartered in Singapore.
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore.
Ark Bio Holding Pte Ltd.
Ark Bio Holding Pte Ltd. Financial ConglomeratesFinance Ark Bio Holding Pte Ltd. operates as an investment holding company. The firm offers end-to-end solutions focused on cancer early detection. The company was founded by Isaac Ho, Zhou Lihan and Zou Ruiyang in 2018 and is headquartered in Singapore. | 6 anni |
| Too Heng-Phon | M | 65 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore.
Ark Bio Holding Pte Ltd.
Ark Bio Holding Pte Ltd. Financial ConglomeratesFinance Ark Bio Holding Pte Ltd. operates as an investment holding company. The firm offers end-to-end solutions focused on cancer early detection. The company was founded by Isaac Ho, Zhou Lihan and Zou Ruiyang in 2018 and is headquartered in Singapore. | 10 anni |
| Isaac Ho | M | - |
Ark Bio Holding Pte Ltd.
Ark Bio Holding Pte Ltd. Financial ConglomeratesFinance Ark Bio Holding Pte Ltd. operates as an investment holding company. The firm offers end-to-end solutions focused on cancer early detection. The company was founded by Isaac Ho, Zhou Lihan and Zou Ruiyang in 2018 and is headquartered in Singapore. | 6 anni |
| Lee Meng Lim | M | 68 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 anni |
| Tai San Noah Lim | M | 49 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 anni |
| Lo Ling Ma | F | 39 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | - |
| Hsien Yang Lee | M | 67 |
National University of Singapore
| 19 anni |
| David Francis Capes | M | 64 |
MiRXES Pte Ltd.
MiRXES Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MiRXES Pte Ltd. is a held life science research tool provider and miRNA diagnostic test developer. Its products and services include IDEAL miRNA knowledge, IDEAL miRNA assays, knowledge panel profiling service, cutomization assay and premium biomarker discovery solution. The company was founded by Zhou Lihan, Zou Ruiyang, and Too Heng Phon and is headquartered in Singapore. | - |
| Beng Lor Choo | M | 52 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 4 anni |
| Dieter Trau | M | - |
National University of Singapore
| 20 anni |
| Yuet Chew Siow | F | 57 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 1 anni |
| Da Liu | M | 53 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 anni |
| Beilin Le | M | 35 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 anni |
| Wei Zhi Owyong | F | - |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Chong Huat Tan | M | 61 |
National University of Singapore
| 6 anni |
| Peng Kheong Leong | M | 64 |
National University of Singapore
| 9 anni |
| Ce Xu | M | 43 |
National University of Singapore
| 5 anni |
| Jack Liu | M | - |
National University of Singapore
| 5 anni |
| De Yuen | M | - |
National University of Singapore
| 4 anni |
| Ashokan Ramakrishnan | M | 50 |
National University of Singapore
| 2 anni |
| Hui Hong Seow | F | - |
National University of Singapore
| 5 anni |
| Willy Hambali | M | 43 |
National University of Singapore
| 4 anni |
| Andrew Choo | M | - |
National University of Singapore
| 4 anni |
| Ritesh Toshniwal | M | - |
National University of Singapore
| 2 anni |
| Eva Tay | F | - |
National University of Singapore
| 4 anni |
| Bobby Sanghavi | M | - |
National University of Singapore
| 2 anni |
| Bin Deng | M | 49 |
National University of Singapore
| 3 anni |
| Devid Kennedy | M | - |
National University of Singapore
| 5 anni |
| Puiyan Leung | F | - |
National University of Singapore
| 4 anni |
| Amy Leo | F | - |
National University of Singapore
| 5 anni |
| Wei Qi Lin | F | 41 |
National University of Singapore
| 4 anni |
| Hai Song Yao | M | 51 |
National University of Singapore
| 1 anni |
| Yu Nan Huang | F | 46 |
National University of Singapore
| 2 anni |
| Guo Liang Huang | M | - |
National University of Singapore
| 4 anni |
| Baojun Ma | M | 61 |
National University of Singapore
| 4 anni |
| Rui Zhang | M | - |
National University of Singapore
| 4 anni |
| Shelby Zhang | M | - |
National University of Singapore
| 2 anni |
| Ngit Liong Wong | M | 83 |
National University of Singapore
| 12 anni |
| Clarence Quek | M | - |
National University of Singapore
| 3 anni |
| Bin Xue | M | 41 |
National University of Singapore
| 2 anni |
| Vicki Yeo | F | - |
National University of Singapore
| 3 anni |
| Kenneth Teo | M | - |
National University of Singapore
| 4 anni |
| Narantuya Lkhagvajav | F | - |
National University of Singapore
| 3 anni |
| Christine Giam | F | - |
National University of Singapore
| 5 anni |
| Ching Man Chow | F | 39 |
National University of Singapore
| 4 anni |
| DEV CHATTERJEE | M | - |
National University of Singapore
| 5 anni |
| Feng Ren | M | 49 |
National University of Singapore
| 1 anni |
| Thulasy Suppiah | F | 40 |
National University of Singapore
| 4 anni |
| Cindy Heng | F | - |
National University of Singapore
| 3 anni |
| Wei Wei Huang | M | - |
National University of Singapore
| 3 anni |
| Jie Xiang Chong | M | 38 |
National University of Singapore
| 3 anni |
| Shi Wei Lay | M | 38 |
National University of Singapore
| 4 anni |
| Jieming Zeng | M | 51 |
National University of Singapore
| 3 anni |
| Tan Chye Leng Terence | M | 55 |
National University of Singapore
| 2 anni |
| Wei Reng Tan | M | 45 |
National University of Singapore
| 4 anni |
| Ryan Li | M | - |
National University of Singapore
| 5 anni |
| Weili Tan | M | - |
National University of Singapore
| 5 anni |
| Ching Yit Tay | M | 45 |
National University of Singapore
| 4 anni |
| Man Chun Leong | M | 40 |
National University of Singapore
| 4 anni |
| Glenn Tan | M | - |
National University of Singapore
| 4 anni |
| Bulbul Ahmed | M | - |
National University of Singapore
| 1 anni |
| Jocelyn Tan | F | - |
National University of Singapore
| 4 anni |
| Gang Wu | M | 66 |
National University of Singapore
| 1 anni |
| Shin Ran Ong | M | 44 |
National University of Singapore
| 4 anni |
| Fred Hsieh | M | - |
National University of Singapore
| 2 anni |
| Yew Kee Ho | M | 60 |
National University of Singapore
| - |
| Usman Sheikh | M | - |
National University of Singapore
| 3 anni |
| Jonathan Tahir | M | 37 |
National University of Singapore
| 4 anni |
| Reza Dehkordy Hamid Behnam | M | - |
National University of Singapore
| 2 anni |
| Guan Liang Tan | M | - |
National University of Singapore
| 1 anni |
| Michelle Lee | F | - |
National University of Singapore
| 4 anni |
| Cheah Chu Yeow | M | - |
National University of Singapore
| 4 anni |
| Poh Kam Wong | M | 72 |
National University of Singapore
| 11 anni |
| Min Chow Sai | F | - |
National University of Singapore
| 4 anni |
| Chang Chieh Hang | M | - |
National University of Singapore
| 12 anni |
| Thong Yuen Poon | M | 49 |
National University of Singapore
| 3 anni |
| Judith Swain | M | 75 |
National University of Singapore
| 11 anni |
| Zaki Mahomed | M | - |
National University of Singapore
| 4 anni |
| Hongmei Wang | F | 55 |
National University of Singapore
| 2 anni |
| Pang Yen Lim | M | 42 |
National University of Singapore
| 4 anni |
| Charles Su | M | - |
National University of Singapore
| 4 anni |
| Srinivas Bhaskar | M | - |
National University of Singapore
| 4 anni |
| Mui Hui Tan | F | 41 |
National University of Singapore
| 4 anni |
| Boon Chiao Koh | M | 44 |
National University of Singapore
| 3 anni |
| Keat Yeow Chew | M | 50 |
National University of Singapore
| 2 anni |
| Kuo Liang Teo | M | 43 |
National University of Singapore
| 4 anni |
| Gandhi Parveen Kumar | M | 64 |
National University of Singapore
| 2 anni |
| Zhen Chen | M | 46 |
National University of Singapore
| 1 anni |
| Zheng Xi Choo | M | 38 |
National University of Singapore
| 3 anni |
| Frenky Tirtowijoyo Susilo | M | 48 |
National University of Singapore
| 2 anni |
| Wei-Han Yeap | M | 40 |
National University of Singapore
| 4 anni |
| Hwei Pink Wong | M | 48 |
National University of Singapore
| 1 anni |
| Leung Pui Yan | F | - |
National University of Singapore
| 4 anni |
| Pei Peng | F | 37 |
National University of Singapore
| 3 anni |
| Cindy Teoh | F | - |
National University of Singapore
| 3 anni |
| Swee Yong Lim | M | - |
National University of Singapore
| 4 anni |
| Li Xin Bao | F | - |
National University of Singapore
| 4 anni |
| Hai Feng Shi | M | 52 |
National University of Singapore
| 1 anni |
| Dinghan Luo | M | - |
National University of Singapore
| 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Singapore | 100 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Zhou Lihan
- Contatti personali
